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Background:  Vaccines induce a transient impairment of endothelial function and arterial elastic properties. New vaccines against the influenza 
A/H1N1 virus are reported to have a safe cardiovascular profile. Their impact on endothelial function and arterial stiffness has not been established.
Methods:  We recruited 14 HIV infected patients (all male, 3 naïve to antiretroviral therapy, mean age 35±10 years) with a good functional status 
(mean CD4 count: 719±273). Flow mediated dilatation (FMD) of the brachial artery was used as an index of endothelial function. Pulse wave 
velocity (PWV) was measured non-invasively. IL-6 and sICAM-1 concentrations were measured from serum samples. Measurements were taken prior 
to, 8h and 48h post vaccination. A single dose of a monovalent, adjuvanted vaccine against influenza A/H1N1 was used.
Results:  Vaccination led to a significant impairment of FMD, denoting a diminished bioavailability of nitric oxide that persisted even after 48h 
(baseline: 6.5±4.8 %, 8h: 2.3±4.9%, 48h: 1.8±4.8 %; p=0.05). Arterial stiffness, as assessed by PWV, was not altered (baseline: 7.2±1.2 m/sec, 8h: 
7.0±1.2 m/sec, 48h:6.8±0.9 m/sec; p=ns). IL6 and sICAM-1 concentrations did not change following vaccination.
Conclusion: Vaccination against influenza A/H1N1 with a monovalent, adjuvanted vaccine leads to endothelial dysfunction in HIV patients, which 
lasts for at least 48 hours. Given the increased cardiovascular risk of these patients, these findings warrant further research. 
